A bill approved last year by the House Appropriations Committee contains dire cuts to funding for the National Institutes of Health. The ACR is urging the House to revise this language and the Senate not to allow these cuts to go through. Contact your legislators to convey the importance of robust investment in the nation’s medical research enterprise and how funding cuts harm patient care.
Got a Private Practice Question? The Community Practice Council Can Help
ACR members in private practice on The Community Practice Council can answer questions, share experiences and offer encouragement to those interested in private practice.
Getting to Know the New Foundation President
Liana Fraenkel, MD, MPH, credits much of her own career success to support from the Foundation, and she is eager to advance its mission during her presidency.
Rheum in the Court, Law in the Clinic: Health Policy in Global Rheumatology
SAN DIEGO—At ACR Convergence 2023, panelists presented information concerning several policy issues that affect rheumatologists & their patients, including abortion access & the WHO’s Essential Medicine List.
Striving for Equity
SAN DIEGO—At ACR Convergence 2023, panelists provided guidance for reducing disparities and improving health equity for patients who are negatively impacted by social determinants of health.
Rheum in the Court, Law in the Clinic: Health Policy in Global Rheumatology
At ACR Convergence 2023, panelists presented information concerning several policy issues that affect rheumatologists & their patients, including abortion access & the WHO’s Essential Medicine List.
The ACR Thanks Members for Supporting RheumPAC During Matching Campaign
This year’s matching campaign raised more than $20,000 from ACR and ARP members and staff and another $7,300 from volunteer leaders.
ACR Advocacy Staff Outline Victories, Challenges from a Busy Year
SAN DIEGO—In an advocacy update session at ACR Convergence 2023, ACR staff described progress in multiple priority areas, including access to care and workforce issues.
Blue Cross NC Revises Autoimmune Pathways Program
After meeting with the ACR and other stakeholders, Blue Cross NC and OMI announced revisions to their Autoimmune Pathways Program to drop biologic tapering requirements and paying providers according to specific treatment decisions.
ACR Advocates with Payers Against Insufficient Reimbursement for Biosimilars
The ACR is engaging with payers regarding formulary requirements that would leave practices underwater when treating patients with rheumatic diseases.
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 149
- Next Page »